Jozefien Declercq

Journal Article
A1
open access

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, Peng Zhang, Jeremy Manry, Yoann Seeleuthner, Yu Zhang, Alexandre Bolze, Matthieu Chaldebas, Baptiste Milisavljevic, et al.

(2023) GENOME MEDICINE. 15.

Add to list

Miscellaneous
open access

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Karel Van Damme (UGent) , Levi Hoste (UGent) , Jozefien Declercq (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes (UGent) , Liesbet Martens (UGent) , Roos Colman (UGent) , Robin Browaeys (UGent) , Cedric Bosteels (UGent) , Stijn Verwaerde (UGent) , et al.

(2023) medRxiv.

Add to list

Journal Article
A1
open access

RNA viruses alter house dust mite physiology and allergen production with no detected consequences for allergenicity

José Cristian Vidal‐Quist, Jozefien Declercq (UGent) , Stijn Vanhee (UGent) , Bart Lambrecht (UGent) , José Gómez‐Rial, Carmen Vidal, Eylem Aydogdu Lohaus (UGent) , Stephane Rombauts (UGent) and Pedro Hernández‐Crespo

(2023) INSECT MOLECULAR BIOLOGY. 32(2). p.173-186

Add to list

Journal Article
A1
open access

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

Cedric Bosteels (UGent) , Karel Van Damme (UGent) , Elisabeth De Leeuw (UGent) , Jozefien Declercq (UGent) , Bastiaan Maes (UGent) , Victor Bosteels (UGent) , Levi Hoste (UGent) , Leslie Naesens (UGent) , Nincy Debeuf (UGent) , Julie Deckers (UGent) , et al.

(2022) CELL REPORTS MEDICINE. 3(12).

Add to list

Journal Article
A1
open access

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial

Elisabeth De Leeuw (UGent) , Karel Van Damme (UGent) , Jozefien Declercq (UGent) , Cedric Bosteels (UGent) , Bastiaan Maes (UGent) , Simon Tavernier (UGent) , Laurent Detalle, Trevor Smart, Sophie Glatt, Nincy Debeuf (UGent) , et al.

(2022) RESPIRATORY RESEARCH. 23(1).

Add to list

Journal Article
A1
open access

Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection : from prognostic marker to therapeutic agent

Jozefien Declercq (UGent) , Elisabeth De Leeuw (UGent) and Bart Lambrecht (UGent)

(2022) CYTOKINE. 157.

Add to list

Journal Article
A1
open access

Granulocyte colony-stimulating factor : missing link for stratification of type 2-high and type 2-low chronic rhinosinusitis patients

Sharon Van Nevel (UGent) , Jozefien Declercq (UGent) , Gabriële Holtappels (UGent) , Bart Lambrecht (UGent) and Claus Bachert (UGent)

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(5). p.1655-1665.e5

Add to list

Journal Article
A1
open access

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

Levi Hoste (UGent) , Lisa Roels (UGent) , Leslie Naesens (UGent) , Victor Bosteels (UGent) , Stijn Vanhee (UGent) , Sam Dupont (UGent) , Cedric Bosteels (UGent) , Robin Browaeys (UGent) , Niels Vandamme (UGent) , Kevin Verstaen (UGent) , et al.

(2022) JOURNAL OF EXPERIMENTAL MEDICINE. 219(2).

Add to list

COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

Jozefien Declercq (UGent) , Els Tobback (UGent) , Stijn Vanhee (UGent) , Natalie De Ruyck (UGent) , Sarah Gerlo (UGent) , Philippe Gevaert (UGent) and Linos Vandekerckhove (UGent)

(2022) ALLERGY. 77(1). p.304-307

Add to list

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

Jozefien Declercq (UGent) , Karel Van Damme (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes (UGent) , Cedric Bosteels (UGent) , Simon Tavernier, Stefanie De Buyser (UGent) , Roos Colman (UGent) , Maya Hites, Gil Verschelden, et al.

(2021) LANCET RESPIRATORY MEDICINE. 9(12). p.1427-1438

Academic Bibliography

Jozefien Declercq

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19

RNA viruses alter house dust mite physiology and allergen production with no detected consequences for allergenicity

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial

Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection : from prognostic marker to therapeutic agent

Granulocyte colony-stimulating factor : missing link for stratification of type 2-high and type 2-low chronic rhinosinusitis patients

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

Contents

Support

Contact